[SCHEDULE 14A INFORMATION Check the appropriate box: ☐ Preliminary Proxy Statement ☐ ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Cleantech Solutions International, Inc. N.A. Payment of Filing Fee (Check the appropriate box): ☒ No fee required. ☐ Fee computed on table below per Ex]
[SCHEDULE 14A INFORMATION Check the appropriate box: ☐ Preliminary Proxy Statement ☐ ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Cleantech Solutions International, Inc. N.A. Payment of Filing Fee (Check the appropriate box): ☒ No fee required. ☐ Fee computed on table below per Ex]
[EXECUTION VERSION Xinyuan Real Estate Co., Ltd. and The entities listed on Schedule I hereto and Citicorp International Limited Indenture Dated as of November 22, 2017 8.875% Senior Notes Due 2020 TABLE OF CONTENTS Page ARTICLE 1 Definitions and Incorporation by Reference Section 1.01. Definitions 2]
[Sinovac Files 2016 Annual Report on Form 20-F and Reports Unaudited Fourth Quarter 2016 Financial Results Fourth Quarter 2016 Financial highlights Ÿ Quarterly sales from continuing operations were $31.4 million compared to $23.0 million in the prior year period, an increase of 36.7%. Sales increased]
[EXECUTION VERSION Xinyuan Real Estate Co., Ltd. and The entities listed on Schedule I hereto and Citicorp International Limited Indenture Dated as of November 22, 2017 8.875% Senior Notes Due 2020 TABLE OF CONTENTS Page ARTICLE 1 Definitions and Incorporation by Reference Section 1.01. Definitions 2]
[Sinovac Files 2016 Annual Report on Form 20-F and Reports Unaudited Fourth Quarter 2016 Financial Results Fourth Quarter 2016 Financial highlights Ÿ Quarterly sales from continuing operations were $31.4 million compared to $23.0 million in the prior year period, an increase of 36.7%. Sales increased]
[Xinyuan Real Estate Co., Ltd. Announces Issuance of US$200,000,000 of 8.875% senior notes due 2020 BEIJING, November 22, 2017 About Xinyuan Real Estate Co., Ltd. Xinyuan Real Estate Co., Ltd. (“Xinyuan”) is an NYSE-listed real estate developer and property manager primarily in China and in other cou]
[] [List of Subsidiaries 1. Sinovac Biotech (Hong Kong) Ltd., a Hong Kong company 2. Sinovac Biotech Co., Ltd., a PRC company 3. Sinovac Research and Development Co., Ltd. (formerly known as Beijing Sinovac Biological Technology Co., Ltd.), a PRC company 4. Sinovac (Dalian) Vaccine Technology Co., Lt]
